Literature DB >> 27095251

Serum triglyceride levels in relation to high-density lipoprotein cholesterol (TG-HDL) ratios as an efficient tool to estimate the risk of sleep apnea syndrome in non-overweight Japanese men.

Yuji Shimizu1, Hiroyuki Yoshimine2, Mako Nagayoshi3, Koichiro Kadota3, Kensuke Takahashi2, Kiyohiro Izumino4, Kenichiro Inoue4, Takahiro Maeda3,5.   

Abstract

OBJECTIVES: Several studies have reported the association between sleep apnea syndrome and insulin resistance. Being overweight is known risk factor both for sleep apnea syndrome and insulin resistance. However, no studies have reported on the association between serum triglyceride levels in relation to high-density lipoprotein cholesterol (TG-HDL) ratios (a marker of insulin resistance) and sleep apnea syndrome accounting for body mass index (BMI) status.
METHODS: Subjects for the present cross-sectional study consisted of 1,528 men aged 30-69 years undergoing pulse oximetry at a sleep disorders clinic for sleep apnea syndrome. Sleep apnea syndrome was diagnosed as a 3 % oxygen desaturation index (ODI) of ≥15 events/h.
RESULTS: Among study participants, 241 men were diagnosed with sleep apnea syndrome. Independent of classical cardiovascular risk factors, TG-HDL was significantly positively associated with sleep apnea syndrome in participants with a BMI <25 kg/m2, but not in participants with a BMI ≥25 kg/m2. The multivariable adjusted odds ratio (OR) and 95 % confidence interval (95 % CI) of sleep apnea syndrome per Log TG-HDL was 2.03 (95 % CI: 1.36-3.03) for a BMI <25 kg/m2 and 1.23 (95 % CI: 0.89-1.70) for a BMI ≥25 kg/m2.
CONCLUSIONS: An independent positive association between TG-HDL levels and risk of sleep apnea syndrome was observed in participants with a BMI of <25 kg/m2, but not in participants with a BMI ≥25 kg/m2. TG-HDL levels could be an efficient tool to estimate the risk of sleep apnea syndrome in non-overweight Japanese men.

Entities:  

Keywords:  HDL-cholesterol; Non-overweight; Sleep apnea syndrome; Triglycerides

Mesh:

Substances:

Year:  2016        PMID: 27095251      PMCID: PMC5305984          DOI: 10.1007/s12199-016-0532-4

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  23 in total

1.  Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance.

Authors:  Antonio González-Chávez; Luis Ernesto Simental-Mendía; Sandra Elizondo-Argueta
Journal:  Cir Cir       Date:  2011 Mar-Apr       Impact factor: 0.361

2.  Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study.

Authors:  A B Newman; F J Nieto; U Guidry; B K Lind; S Redline; T G Pickering; S F Quan
Journal:  Am J Epidemiol       Date:  2001-07-01       Impact factor: 4.897

3.  Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea.

Authors:  Jamie C M Lam; Kathryn C B Tan; Agnes Y K Lai; David C L Lam; Mary S M Ip
Journal:  Sleep Med       Date:  2011-12-03       Impact factor: 3.492

4.  Assessment of screening tests for sleep apnea syndrome in the workplace.

Authors:  Shigemi Tanaka; Masayuki Shima
Journal:  J Occup Health       Date:  2010-01-28       Impact factor: 2.708

5.  [Risk factors in development of sleep apnea syndrome--a large population study using a simple monitoring system].

Authors:  Ryoichi Suzuki; Tsuneto Akashiba; Osamu Saito; Takashi Horie
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2002-08

6.  Prevalence of obstructive sleep apnoea in men with type 2 diabetes.

Authors:  S D West; D J Nicoll; J R Stradling
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

7.  Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.

Authors:  Shinya Makino; Hiroshi Handa; Koji Suzukawa; Masayoshi Fujiwara; Masaharu Nakamura; Shogo Muraoka; Ikumi Takasago; Yasushi Tanaka; Kozo Hashimoto; Tamotsu Sugimoto
Journal:  Clin Endocrinol (Oxf)       Date:  2006-01       Impact factor: 3.478

8.  Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

Authors:  R Bucala; Z Makita; G Vega; S Grundy; T Koschinsky; A Cerami; H Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Use of metabolic markers to identify overweight individuals who are insulin resistant.

Authors:  Tracey McLaughlin; Fahim Abbasi; Karen Cheal; James Chu; Cindy Lamendola; Gerald Reaven
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study.

Authors:  Antony D Karelis; Stephanie M Pasternyk; Lyne Messier; David H St-Pierre; Jean-Marc Lavoie; Dominique Garrel; Rémi Rabasa-Lhoret
Journal:  Appl Physiol Nutr Metab       Date:  2007-12       Impact factor: 2.665

View more
  2 in total

1.  Comparison of Composite Lipid Indices in Patients with Obstructive Sleep Apnoea.

Authors:  Andras Bikov; Stefan Frent; Daniela Reisz; Alina Negru; Laura Gaita; Daniel Breban Schwarzkopf; Stefan Mihaicuta
Journal:  Nat Sci Sleep       Date:  2022-07-27

2.  Atherogenic Index of Plasma in Obstructive Sleep Apnoea.

Authors:  Andras Bikov; Martina Meszaros; Laszlo Kunos; Alina Gabriela Negru; Stefan Marian Frent; Stefan Mihaicuta
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.